A revised definition for cure of childhood acute lymphoblastic leukemia. - Test2 - elhamkhani - TriplyDB

A revised definition for cure of childhood acute lymphoblastic leukemia.

A revised definition for cure of childhood acute lymphoblastic leukemia.

http://www.wikidata.org/entity/Q34429332

about

Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration Antileukemia Effect of Ciclopirox Olamine Is Mediated by Downregulation of Intracellular Ferritin and Inhibition β-Catenin-c-Myc Signaling Pathway in Glucocorticoid Resistant T-ALL Cell Lines TESTIN Induces Rapid Death and Suppresses Proliferation in Childhood B Acute Lymphoblastic Leukaemia Cells.Protracted dormancy of pre-leukemic stem cells.A retrospective analysis of treatment-related hospitalization costs of pediatric, adolescent, and young adult acute lymphoblastic leukemia Acute respiratory infections in children and adolescents with acute lymphoblastic leukemia.Minimal Residual Disease Evaluation in Childhood Acute Lymphoblastic Leukemia: An Economic Analysis.The clerodane diterpene casearin J induces apoptosis of T-ALL cells through SERCA inhibition, oxidative stress, and interference with Notch1 signaling.Epigenetics in T-cell acute lymphoblastic leukemia.Economic evaluation of rituximab in addition to standard of care chemotherapy for adult patients with acute lymphoblastic leukemia.Targeting BET proteins improves the therapeutic efficacy of BCL-2 inhibition in T-cell acute lymphoblastic leukemia.Mechanism of ETV6-RUNX1 Leukemia.Excellent outcome of minimal residual disease-defined low-risk patients is sustained with more than 10 years follow-up: results of UK paediatric acute lymphoblastic leukaemia trials 1997-2003.Prospective study of thromboembolism in 1038 children with acute lymphoblastic leukemia: a Nordic Society of Pediatric Hematology and Oncology (NOPHO) study.Translation and Clinical Development of Bispecific T-cell Engaging Antibodies for Cancer Treatment.Role of neuroimaging in children with acute lymphoblastic leukemia and central nervous system involvement at diagnosis.High expression of connective tissue growth factor accelerates dissemination of leukaemia.Treatment delay and the risk of relapse in pediatric acute lymphoblastic leukemia.Risk assessment of relapse by lineage-specific monitoring of chimerism in children undergoing allogeneic stem cell transplantation for acute lymphoblastic leukemia The effect of body mass index at diagnosis on clinical outcome in children with newly diagnosed acute lymphoblastic leukemia.Outcome of pediatric acute lymphoblastic leukemia with very late relapse: a retrospective analysis by the Tokyo Children's Cancer Study Group (TCCSG).KLF4 represses MAP2K7 signaling in T-ALL.Recent advances in the management of pediatric acute lymphoblastic leukemia.High prevalence of relapse in children with Philadelphia-like acute lymphoblastic leukemia despite risk-adapted treatment.Modifying bone mineral density, physical function, and quality of life in children with acute lymphoblastic leukemia.Treatment for childhood acute lymphoblastic leukemia in Taiwan: Taiwan Pediatric Oncology Group ALL-2002 study emphasizing optimal reinduction therapy and central nervous system preventive therapy without cranial radiation.Toxicity associated with intensive postinduction therapy incorporating clofarabine in the very high-risk stratum of patients with newly diagnosed high-risk B-lymphoblastic leukemia: A report from the Children's Oncology Group study AALL1131.Diagnosis of central nervous system relapse of pediatric acute lymphoblastic leukemia: Impact of routine cytological CSF analysis at the time of intrathecal chemotherapy.Using decision modeling to guide drug allocation during a shortage.Abnormal correlation of circulating endothelial progenitor cells and endothelin-1 concentration may contribute to the development of arterial hypertension in childhood acute lymphoblastic leukemia survivors.Pre-B acute lymphoblastic leukaemia recurrent fusion, EP300-ZNF384, is associated with a distinct gene expression.Prognostic significance of copy number alterations in adolescent and adult patients with precursor B acute lymphoblastic leukemia enrolled in PETHEMA protocols.Thromboembolism in acute lymphoblastic leukemia: results of NOPHO ALL2008 protocol treatment in patients aged 1 to 45 years.Expression of miR-652-3p and Effect on Apoptosis and Drug Sensitivity in Pediatric Acute Lymphoblastic Leukemia.

P2860

Q28087637-B2688CA0-5EE4-4193-B607-B04F8B676CEC Q28553697-6D0032CC-642B-43A8-9994-56D994DEFF42 Q35960563-A670B758-97CC-4D2B-B0F9-3AA2289E9F86 Q36045125-45AC7B7D-478D-4DB1-BE7B-9A12952D4A2F Q36528384-25FA1D25-B6AA-4514-B2AE-C5C007A9ED55 Q36609554-451C5ACF-44FC-4253-8179-6D2011336476 Q36731638-43A0E85E-2052-4483-8AE2-75F09195D430 Q36751787-D36127F5-5149-4EF9-BCFF-6B329816752F Q38289023-1B25E1CC-BD5D-4649-A11E-AF02A6650E97 Q38610250-B6C68991-C222-4722-8D71-1674989AEC06 Q38722012-4867A1D3-CD75-4FA8-B510-38631D82FE5E Q38744459-19CA458A-6CE0-46EC-A8BC-CAC1CD8007A1 Q38909642-7B58C7FD-9C95-416D-A7F1-A6F0310DA94E Q38927735-2F68476D-DAD0-471D-9BA1-E876FA15CC51 Q39128240-9FC17746-38D2-4DC2-BD08-5441422B0E59 Q39459920-8B963472-9774-4EE0-A20E-EC1B53AF0860 Q40068307-8112DDE7-94FE-4E8F-8909-24A744003233 Q40296977-27B88FE9-0EB2-439A-9EBA-C437ECEFE228 Q41032396-403A8946-583D-4B4A-93EC-590E0605E0A2 Q42339287-C4800D0A-650D-4B84-A687-CAD49CF554C0 Q43794676-23AFF54B-93C3-42DD-81B6-1790F2B5B456 Q44793596-8AB4985F-FEC4-4C60-8DBB-19F73838E5AC Q45105040-8E9DA30F-D3FF-46C1-9297-A0EF7DF563F3 Q47142310-F66808D4-90FC-454B-A308-B147D435610F Q47298947-07709D5A-8B13-4F7F-8BD5-076CC89283B4 Q48039932-5B8769D5-8710-4045-A57F-4DE978C6C151 Q48369402-2ECA5077-2DF5-44F5-A5FC-CD583053A743 Q48549419-6922AB9C-AA60-4697-B4C7-B665252FDF7E Q51059873-FFBE7E7B-4D2A-4A98-B7D7-EF1FBEE93856 Q51474863-F0B806AE-8E18-425A-9FD5-EA88CD99CCE4 Q52659464-141F0CD7-9EE8-4E82-9C88-C67C22A4EB35 Q53831155-1C9F4C85-E13D-4591-8289-0FB5D455576B Q55383390-159CDDA7-F49C-4087-9DC7-C0476E08C6BE Q55434312-27EF276A-C3C8-48D3-9069-3534496085B9

P2860

A revised definition for cure of childhood acute lymphoblastic leukemia.

http://www.wikidata.org/entity/Q34429332

description

2014 nî lūn-bûn

@nan

2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

A revised definition for cure of childhood acute lymphoblastic leukemia.

@ast

A revised definition for cure of childhood acute lymphoblastic leukemia.

@en

A revised definition for cure of childhood acute lymphoblastic leukemia.

@nl

type

label

A revised definition for cure of childhood acute lymphoblastic leukemia.

@ast

A revised definition for cure of childhood acute lymphoblastic leukemia.

@en

A revised definition for cure of childhood acute lymphoblastic leukemia.

@nl

prefLabel

A revised definition for cure of childhood acute lymphoblastic leukemia.

@ast

A revised definition for cure of childhood acute lymphoblastic leukemia.

@en

A revised definition for cure of childhood acute lymphoblastic leukemia.

@nl

P1433

Q34429332-D15CD5DC-02A0-4A21-9741-BD4163008E69

P1476

Q34429332-07CA5CAD-2A32-4AE3-A3D7-C911D4E44550

P2093

Q34429332-0649EE49-D674-4C7B-B815-C76237E88A5B

Q34429332-0D1B125F-F86F-4735-883D-4DB4C0AC3497

Q34429332-13DAD5AF-3D2F-40A1-8E22-E77B6DBC8299

Q34429332-46A26230-7804-45CE-85A5-439022678903

Q34429332-49047747-D16D-41DC-8C81-E897197B79FB

Q34429332-4F575451-3CD5-4A39-B149-DB5BD54C887A

Q34429332-57A6BB8E-09FC-419C-8FC6-7AF68B93AF70

Q34429332-6D9BD67B-ED5E-4A80-B2DB-B93D74B37C6F

Q34429332-70D12B07-50D2-4B4A-B7E9-C20B7326DDA9

Q34429332-73638F01-724A-43E0-8EE0-A19BE0FC18EC

P2860

Q34429332-07F3DA6A-4747-456E-AD8B-BE30D521BC1D

Q34429332-11C6700A-1B89-46FF-90F8-C62BAB8F6654

Q34429332-2586E187-F8C8-4F35-97DD-94F7401E3DBF

Q34429332-28BA4374-8693-4E4C-970A-948BB33685FD

Q34429332-3D812A4E-DC8C-429D-BC05-2B102821CB97

Q34429332-485D3F1A-B990-41DA-AC97-872ECF37C44F

Q34429332-639DE5CD-5E59-4B13-93EA-B506F5371F99

Q34429332-6504FE1F-0040-4E72-B583-7BF9931EBCC0

Q34429332-65366003-2618-458E-A27A-FB89E3CDA0BE

Q34429332-68444AC4-E836-4DC5-9860-96A9E45C28A1

P2888

Q34429332-639011EC-7B8B-452E-8E45-98E1671910C1

P304

Q34429332-03E149D2-29D4-473F-B22D-4E417FF2EC8D

P31

Q34429332-26687ED3-C35D-4251-B6CA-35BD9F9063D2

P356

Q34429332-6E3D9D2D-2E2F-4A47-A85E-B007A9541054

P433

Q34429332-0CF844C4-E587-4B02-A5CA-292181766300

P478

Q34429332-2F1BDBE7-9E51-4DA6-88AA-1037FDF8B55A

P50

Q34429332-2BCF9D4C-FDD8-4125-B417-AB6DE794A21C

Q34429332-7EA72BBF-6785-4357-A960-50E81A198C18

P577

Q34429332-C07C8EB4-DE01-41FA-91BF-C7005E77395E

P5875

Q34429332-05CD1A4D-A99C-4EC6-AE70-1DCEA9E4031A

P6179

Q34429332-536724D4-A236-4CE3-9317-4A0BCA3C3C2F

P698

Q34429332-6CE42C24-B303-4B2F-9DFF-659583CB4D99

P921

Q34429332-B247AA77-323D-48BE-BD27-BBB377807DF2

P932

Q34429332-76F8681C-3898-4579-BF9B-9062865D79A7

P356

P1433

P1476

A revised definition for cure of childhood acute lymphoblastic leukemia

@en

P2093

C Cheng

http://www.w3.org/2001/XMLSchema#string

C H Pui

http://www.w3.org/2001/XMLSchema#string

D Campana

http://www.w3.org/2001/XMLSchema#string

D Pei

http://www.w3.org/2001/XMLSchema#string

E Coustan-Smith

http://www.w3.org/2001/XMLSchema#string

H Inaba

http://www.w3.org/2001/XMLSchema#string

J R Downing

http://www.w3.org/2001/XMLSchema#string

J T Sandlund

http://www.w3.org/2001/XMLSchema#string

M L Metzger

http://www.w3.org/2001/XMLSchema#string

M M Hudson

http://www.w3.org/2001/XMLSchema#string

P2860

Treating childhood acute lymphoblastic leukemia without cranial irradiation

More powerful procedures for multiple significance testing

Non-parametric confidence interval estimation for competing risks analysis: application to contraceptive data.

Long-term results of St Jude Total Therapy Studies 11, 12, 13A, 13B, and 14 for childhood acute lymphoblastic leukemia.

Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM Study Group.

Clinical significance of low levels of minimal residual disease at the end of remission induction therapy in childhood acute lymphoblastic leukemia.

Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children's oncology group.

Pediatric acute lymphoblastic leukemia: where are we going and how do we get there?

Imatinib after induction for treatment of children and adolescents with Philadelphia-chromosome-positive acute lymphoblastic leukaemia (EsPhALL): a randomised, open-label, intergroup study

Cognitive outcomes following contemporary treatment without cranial irradiation for childhood acute lymphoblastic leukemia.

P2888

P304

2336-2343

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/LEU.2014.142

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P50

Jeffrey Rubnitz

P577

2014-04-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261996701

http://www.w3.org/2001/XMLSchema#string

P6179

1003487191

http://www.w3.org/2001/XMLSchema#string

P698

24781017

http://www.w3.org/2001/XMLSchema#string

P921

P932

4214904

http://www.w3.org/2001/XMLSchema#string